Sermet-Gaudelus I - Search Results

1

CFTR: New insights into structure and function and implications for modulation by small molecules.

Kleizen B, Hunt JF, Callebaut I, Hwang TC, Sermet-Gaudelus I, Hafkemeyer S, Sheppard DN. Kleizen B, et al. J Cyst Fibros. 2020 Mar;19 Suppl 1:S19-S24. doi: 10.1016/j.jcf.2019.10.021. Epub 2019 Nov 21. J Cyst Fibros. 2020. PMID: 31759907 Free article.

2

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?

Witko-Sarsat V, Sermet-Gaudelus I, Lenoir G, Descamps-Latscha B. Witko-Sarsat V, et al. Mediators Inflamm. 1999;8(1):7-11. doi: 10.1080/09629359990658. Mediators Inflamm. 1999. PMID: 10704083 Free PMC article. Review.

3

[New therapeutic approaches to Cystic fibrosis].

Willemot JM, Sermet Gaudelus I, Lenoir G. Willemot JM, et al. Ann Pharm Fr. 2003 Jul;61(4):253-8. Ann Pharm Fr. 2003. PMID: 12843958 Review. French.

4

Basic protocol for transepithelial nasal potential difference measurements.

Schüler D, Sermet-Gaudelus I, Wilschanski M, Ballmann M, Dechaux M, Edelman A, Hug M, Leal T, Lebacq J, Lebecque P, Lenoir G, Stanke F, Wallemacq P, Tümmler B, Knowles MR. Schüler D, et al. J Cyst Fibros. 2004 Aug;3 Suppl 2:151-5. doi: 10.1016/j.jcf.2004.05.032. J Cyst Fibros. 2004. PMID: 15463949 Free article. Review.

5

Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone.

Le Heron L, Guillaume C, Velard F, Braux J, Touqui L, Moriceau S, Sermet-Gaudelus I, Laurent-Maquin D, Jacquot J. Le Heron L, et al. J Cyst Fibros. 2010 Jan;9(1):69-72. doi: 10.1016/j.jcf.2009.11.005. Epub 2009 Dec 14. J Cyst Fibros. 2010. PMID: 20005786 Free article.

6

Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening.

Sermet-Gaudelus I, Mayell SJ, Southern KW; European Cystic Finrosis Society (ECFS), Neonatal Screening Working Group. Sermet-Gaudelus I, et al. J Cyst Fibros. 2010 Sep;9(5):323-9. doi: 10.1016/j.jcf.2010.04.008. J Cyst Fibros. 2010. PMID: 20605539 Free article.

7

European cystic fibrosis bone mineralisation guidelines.

Sermet-Gaudelus I, Bianchi ML, Garabédian M, Aris RM, Morton A, Hardin DS, Elkin SL, Compston JE, Conway SP, Castanet M, Wolfe S, Haworth CS. Sermet-Gaudelus I, et al. J Cyst Fibros. 2011 Jun;10 Suppl 2:S16-23. doi: 10.1016/S1569-1993(11)60004-0. J Cyst Fibros. 2011. PMID: 21658635 Free article.

8

Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect.

Colas J, Faure G, Saussereau E, Trudel S, Rabeh WM, Bitam S, Guerrera IC, Fritsch J, Sermet-Gaudelus I, Davezac N, Brouillard F, Lukacs GL, Herrmann H, Ollero M, Edelman A. Colas J, et al. Hum Mol Genet. 2012 Feb 1;21(3):623-34. doi: 10.1093/hmg/ddr496. Epub 2011 Oct 28. Hum Mol Genet. 2012. PMID: 22038833 Free PMC article.

9

Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation.

Sermet-Gaudelus I. Sermet-Gaudelus I. Eur Respir Rev. 2013 Mar 1;22(127):66-71. doi: 10.1183/09059180.00008512. Eur Respir Rev. 2013. PMID: 23457167 Free PMC article. Review.

10

[Cystic fibrosis: new treatments targeting the CFTR protein].

Fajac I, Sermet-Gaudelus I. Fajac I, et al. Rev Mal Respir. 2013 Apr;30(4):255-61. doi: 10.1016/j.rmr.2012.10.631. Epub 2013 Jan 11. Rev Mal Respir. 2013. PMID: 23664284 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page